Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 6/20 | 0.46 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21518399 | 1.00 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL17923275 | 1.00 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL18747632 | 0.98 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| Hydrochloric Acid SCHEMBL29233618 | 0.98 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL21518383 | 0.98 | CXCR4 (0.44) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL918578 | 0.96 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL37872 | 0.96 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL21518374 | 0.96 | CXCR4 (0.46) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| SCHEMBL3857080 | 0.94 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 | |
| Ammonia Solution, Strong SCHEMBL4735488 | 0.94 | CXCR4 (0.45) | CXCR4CXCL12KMT2AHRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094998-A | Water-dispersible blocked isocyanate prepolymer systems, process for their preparation and their use | — | 2026-05-26 | — | — | CN | claimed |
| EP-4739789-A1 | SAMPLE LYSIS PROCEDURE FOR DIRECT PCR MOLECULAR DIAGNOSTIC | miDiagnostics NV (BE) | 2026-05-13 | — | — | EP | claimed |
| EP-4735620-A1 | METHODS AND FORMULATIONS FOR DENATURING DNA | Illumina, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4724588-A1 | A METHOD OF ENHANCED SEPARATION OF FULL ADENO-ASSOCIATED VIRUS (AAV) CAPSIDS | Sartorius BIA Separations d.o.o. (SI) | 2026-04-15 | — | — | EP | claimed |
| US-12582670-B2 | Lignin solvation using aqueous biologically compatible buffers | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-03-24 | — | — | US | claimed |
| US-20250325257-A1 | INGESTIBLE CAPSULE DEVICE | LILLY CO ELI (US) | 2025-10-23 | — | — | US | claimed |
| WO-2025217418-A1 | SAMPLE PREPARATION FOR NUCLEIC ACIDS | Life Technologies Corporation (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025108924-A1 | WATER-DISPERSIBLE BLOCKED ISOCYANATE PREPOLYMER SYSTEM, METHOD FOR PREPARING THE SAME, AND APPLICATION THEREOF | COVESTRO DEUTSCHLAND AG (DE) | 2025-05-30 | — | — | WO | claimed |
| CN-120025522-A | Water-dispersible blocked isocyanate prepolymer systems, process for their preparation and their use | 科思创德国股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250154312-A1 | HYDROPHILICALLY MODIFIED POLYISOCYANATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | WANHUA CHEMICAL GROUP CO LTD (CN) | 2025-05-15 | — | — | US | claimed |
| EP-1473299-A2 | Isolation of nucleid acids | DNA Research Innovations Limited (GB) | 2004-11-03 | — | — | EP | claimed |
| US-20040209015-A1 | Additives for use in print media to reduce bronzing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2004-10-21 | — | — | US | claimed |
| EP-1468836-A2 | Print medium having reduced bronzing and method of producing the same | Hewlett-Packard Development Company, L.P. (US) | 2004-10-20 | — | — | EP | claimed |
| EP-1345952-A2 | ISOLATION OF NUCLEIC ACIDS | DNA Research Innovations Limited (GB) | 2003-09-24 | — | — | EP | claimed |
| US-20030054395-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2003-03-20 | — | — | US | claimed |
| US-20030008320-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2003-01-09 | — | — | US | claimed |
| US-20020195341-A1 | Alkaline pH, free solution capillary electrophoresis method | SEBIA (FR) | 2002-12-26 | — | — | US | claimed |
| WO-2002048164-A2 | ISOLATION OF NUCLEIC ACIDS | DNA RESEARCH INNOVATIONS LIMITED (GB) | 2002-06-20 | — | — | WO | claimed |
| WO-2001075155-A2 | METHODS FOR DETECTING OF NUCLEIC ACID AMPLIFICATION REACTION PRODUCTS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2001-10-11 | — | — | WO | claimed |
| US-20010018513-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2001-08-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582670-B2 | Lignin solvation using aqueous biologically compatible buffers | HCLS1, ASNS, EPAS1 | CXCR4 4723/4885CXCL12 3003/4885KMT2A 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.